WHO. Noncommunicable diseases. 2018. http://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed 20 Sept 2020.
Kruk ME, Nigenda G, Knaul FM. Redesigning primary care to tackle the global epidemic of noncommunicable disease. Am J Public Health. 2015;105:431–7.
Article
Google Scholar
WHO. Noncommunicable diseases: the slow‑motion disaster. 2017.
World Health Organisation. Non communicable disease progress monitor 2017. Geneva; 2017.
NCD Alliance. The financial burden of NCDs. https://ncdalliance.org/why-ncds/the-financial-burden-of-ncds. Accessed 11 Dec 2020.
Escobar M-L, Griffin CC, Shaw RP. The impact of health insurance in low- and middle-income countries. Brookings Institution Press; 2010.
Heeley E, Anderson CS, Huang Y, Jan S, Li Y, Liu M, et al. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke. 2009;40(6):2149–56.
Article
Google Scholar
Elrayah H, Eltom M, Bedri A, Belal A, Rosling H, Östenson CG. Economic burden on families of childhood type 1 diabetes in urban Sudan. Diabetes Res Clin Pract. 2005;70(2):159–65.
Article
Google Scholar
Naushin M, Syed MA. The disease pattern and utilisation of health care services in Pakistan. 2002. https://www.jstor.org/stable/41263378?seq=1#metadata_info_tab_contents. Accessed 25 Mar 2021.
Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D. Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. Lancet. 2017;389:951–63.
Article
Google Scholar
Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 34. Lancet. 2018;392:1072–88.
Article
Google Scholar
Beaglehole R, Ruth B, Richard H, George A, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;6:1438–47.
Article
Google Scholar
Geneau R, Stuckler D, Stachenko S, McKee M, Ebrahim S, Basu S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet. 2010;376(9753):1689–98. https://doi.org/10.1016/S0140-6736(10)61414-6.
Article
PubMed
Google Scholar
Vandenberghe D, Albrecht J. The financial burden of non-communicable diseases in the European Union: a systematic review. Eur J Public Health. 2019. https://doi.org/10.1093/eurpub/ckz073.
Article
Google Scholar
Murphy A, Palafox B, Walli-Attaei M, Powell-Jackson T, Rangarajan S, Alhabib KF, et al. The household economic burden of non-communicable diseases in 18 countries. BMJ Glob Health. 2020;5(2):e002040.
Article
Google Scholar
Kankeu HT, Saksena P, Xu K, Evans DB. The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst. 2013. https://doi.org/10.1186/1478-4505-11-31.
Article
PubMed
PubMed Central
Google Scholar
Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA. Out-of-pocket health-care expenditures among older Americans with cancer. Value Health. 2004;7(2):186–94.
Article
Google Scholar
Pollack CE, Griffin BA, Lynch J. Housing affordability and health among homeowners and renters. Am J Prev Med. 2010;39(6):515–21.
Article
Google Scholar
Schofield D, Passey M, Percival R, Shrestha R, Callander E, Kelly S. Retiring early with cardiovascular disease—impact on individual’s financial assets. Int J Cardiol. 2011;146(1):125–6.
Article
Google Scholar
Lin J-MS, Resch SC, Brimmer DJ, Johnson A, Kennedy S, Burstein N, et al. The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs. Cost Eff Resour Alloc. 2011;9(1):1. http://resource-allocation.biomedcentral.com/articles/https://doi.org/10.1186/1478-7547-9-1.
Barrett AM, Colosia AD, Boye KSOO. Burden of obesity: 10-year review of the literature on costs in nine countries. Value Health. 2008. https://doi.org/10.1016/S1098-3015(10)70508-8.
Article
Google Scholar
World Health Organisation. Global status report on noncommunicable diseases 201 4 “Attaining the nine global noncommunicable diseases targets; a shared responsibility”. Geneva; 2014. https://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_eng.pdf. Accessed 23 Feb 2021.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: elaboration and explanation. BMJ. 2015;349(January):1–25. https://doi.org/10.1136/bmj.g7647.
Article
Google Scholar
Claeson M, Griffin CC, Johnston TA, Mclachlan M, Soucat ALB, Wagstaff A, et al. Health, nutrition, and population. Washington; 2001. https://d1wqtxts1xzle7.cloudfront.net/42656824/hnp.pdf?1455402221=&response-content-disposition=inline%3B+filename%3DChapter_18_Health_Nutrition_and_Populati.pdf&Expires=1607707225&Signature=Tc2LQ6b3BY6sj9RMHWiC1aUwTB9EUCf2ArGCtJgAAGNna3X6VO7-5-mOQmmd2cURXboDRwSMlCZlxpnOVlQwqvTN3np6RUt6MTErZUh7YbrdRudZ~sCkc7qdKV08LQXkpuiYcOOi7JERw5OIhCf-eOJ46OGGgqWUA4cYD3rIe0WmfstolxxA5mCVVbQQwZ-Hm58DdBbEPxvb0yw5vzsiv8EFDHwuGg7Hkuhbxz8B9CRUuIIyjxI9phMHuN8QYMUq4oYpCr3999UpTQH-AJrfCbg0AodZboIA5U9SeSAkQIyuplCT2lFdkPmU7RBJUXAEgicHWanb37bPzCJGNzkCmQ__&Key-Pair-Id=APKAJLOHF5GGSLRBV4ZA. Accessed 11 Dec 2020.
McIntyre D, Thiede M, Dahlgren G, Whitehead M. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Soc Sci Med. 2006;62(4):858–65.
Article
Google Scholar
Tawfik GM, Dila KAS, Mohamed MYF, Tam DNH, Kien ND, Ahmed AM, et al. A step by step guide for conducting a systematic review and meta-analysis with simulation data. Trop Med Health. BioMed Central Ltd.; 2019; 46. https://tropmedhealth.biomedcentral.com/articles/https://doi.org/10.1186/s41182-019-0165-6. Accessed 23 Feb 2021.
The World Bank Group. World Bank country and lending groups—world bank data help desk. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed 3 Jun 2019.
Veronese N, Cereda E, Solmi M, Fowler SA, Manzato E, Maggi S, et al. Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjects. Obes Rev. 2015;16(11):1001–15.
Article
CAS
Google Scholar
Luchini C, Stubbs B, Solmi M, Veronese N. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal. 2017;5(4):80. http://www.wjgnet.com/2308-3840/full/v5/i4/80.htm. Accessed 21 Jun 2020.
Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition). J Chin Integr Med. 2009;7(9):889–96.
Article
Google Scholar
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016. https://doi.org/10.1186/s13643-016-0384-4.
Article
PubMed
PubMed Central
Google Scholar
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Article
Google Scholar
Stang A, Jonas S, Poole C. Case study in major quotation errors: a critical commentary on the Newcastle-Ottawa scale. Eur J Epidemiol. 2018;33:1025–31.
Article
CAS
Google Scholar
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos MPT. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2019. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 26 Jun 2019.
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute . 2019. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 23 Feb 2021.
World Bank. Consumer price index (2010 = 100). https://data.worldbank.org/indicator/FP.CPI.TOTL?end=2019&locations=TH&start=1960&view=chart. Accessed 23 Mar 2020.
The World Bank. Official exchange rate (LCU per US$, period average). https://data.worldbank.org/indicator/PA.NUS.FCRF?locations=TH. Accessed 23 Mar 2020.
WHO. Geographical WHO Regions. https://www.who.int/choice/demography/wpacific_region/en/. Accessed 25 Feb 2020.
El-Sayed AM, Vail D, Kruk ME. Ineffective insurance in lower and middle income countries is an obstacle to universal health coverage. J Glob Health. 2018. https://doi.org/10.7189/jogh.08.020402.
Article
PubMed
PubMed Central
Google Scholar
The World Bank. World development indicators. Washington DC; 2008. http://documents.worldbank.org/curated/en/587251468176971009/pdf/541670WDI0200810Box345641B01PUBLIC1.pdf. Accessed 25 May 2020.
Bollyky T. Why chemotherapy that costs $70,000 in the U.S. costs $2500 in India—The Atlantic. The Atlantic. 2013. https://www.theatlantic.com/health/archive/2013/04/why-chemotherapy-that-costs-70-000-in-the-us-costs-2-500-in-india/274847/. Accessed 25 May 2020.
Goldstein DA, Clark J, Tu Y, Zhang J, Fang F, Goldstein R, et al. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth. Oncotarget. 2017;8(42):71548.
Article
Google Scholar
Ngalesoni F, Ruhago G, Norheim OF, Robberstad B. Economic cost of primary prevention of cardiovascular diseases in Tanzania. Health Policy Plan. 2015.30(7):875–84. https://academic.oup.com/heapol/article/30/7/875/827199. Accessed 25 May 2020.
Sorenson C, Drummond M, Khan BB. Medical technology as a key driver of rising health expenditure: disentangling the relationship. Clin Outcomes Res. 2013;5(1):223–34.
Article
Google Scholar
World Health Organisation. Burden of COPD. WHO. World Health Organization; 2011. https://www.who.int/respiratory/copd/burden/en/. Accessed 19 Apr 2020.
Martínez- Briseño D, Fernández-Plata R, García-Sancho C, Cano-Jiménez D, Sansores-Martínez R, Ramíres-Venegas A, et al. Out-of-pocket expenses for COPD patients in a third level hospital. Value Health. 2015;18(3):A173.
Article
Google Scholar
Stafyla E, Geitona M, Kerenidi T, Economou A, Daniil Z, Gourgoulianis K. The annual direct costs of stable COPD in Greece. Int J Chron Obstruct Pulmon Dis. 2018;13:309–15. https://www.dovepress.com/the-annual-direct-costs-of-stable-copd-in-greece-peer-reviewed-article-COPD. Accessed 25 May 2020.
Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374:721–32.
Article
Google Scholar
Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015. https://doi.org/10.7189/jogh.05.020415.
Article
PubMed
PubMed Central
Google Scholar
Subramanian S, Gakunga R, Kibachio J, Gathecha G, Edwards P, Ogola E, et al. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: patient payments in the private and public sectors. PLoS ONE. 2018;13(1):1–16.
Article
CAS
Google Scholar
Jaspers L, Colpani V, Chaker L, van der Lee SJ, Muka T, Imo D, et al. The global impact of non-communicable diseases on households and impoverishment: a systematic review. Eur J Epidemiol. 2014;30(3):163–88.
Article
Google Scholar
Di Cesare M, Khang YH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381(9866):585–97.
Article
Google Scholar
The World Bank. GDP per capita (current US$)—low income | Data. https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=XM. Accessed 24 Mar 2020.
Ezat Wan Puteh S, Almualm Y. Catastrophic health expenditure among developing countries. Health Syst Policy Res. 2017. https://doi.org/10.21767/2254-9137.100069.
Article
Google Scholar
Bollyky TJ, Templin T, Cohen M, Dieleman JL. Lower-income countries that face the most rapid shift in noncommunicable disease burden are also the least prepared. Health Aff. 2017;36(11):1866–75. http://www.healthaffairs.org/doi/https://doi.org/10.1377/hlthaff.2017.0708. Accessed 25 May 2020.
Essue BM, Kimman M, Svenstrup N, Kjoege KL, Laba TL, Hackett ML, et al. The effectiveness of interventions to reduce the household economic burden of illness and injury: a systematic review. Bull World Health Org. 2015;93:102-112B.
Article
Google Scholar
Kankeu H, Saksena P, Xu K, Evans DB. The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst. 2013;11(1):1–12.
Article
Google Scholar
WHO. Countries are spending more on health, but people are still paying too much out of their own pockets. WHO. 2019. https://www.who.int/news-room/detail/20-02-2019-countries-are-spending-more-on-health-but-people-are-still-paying-too-much-out-of-their-own-pockets. Accessed 25 May 2020.
Fuady A, Houweling TAJ, Mansyur M, Richardus JH. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia’s implementation of universal health coverage. Infect Dis Poverty. 2018;7(1):3. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med13&AN=29325589http://pmt-eu.hosted.exlibrisgroup.com/openurl/46KIB_INST/46KIB_INST_services_page?sid=OVID:medline&id=pmid:29325589&id=doi:10.1186%2Fs40249-017-0382-3&issn=2049-9957&i.
Evans DB, Elovainio R, Humphreys G. The world health report—health systems financing: the path to universal coverage. Geneva; 2010. http://www.who.int/whr/2010/10_summary_en.pdf?ua=1.
Guy Carrin A, Evansa D, Xua K. Designing health financing policy towards universal coverage. Bull World Heal Organ. 2007. https://www.scielosp.org/pdf/bwho/2007.v85n9/652-652.
World Health Organisation. Regional high-level consultation in the Eastern Mediterranean region on the prevention and control of non-communicable diseases in low-and middle-income countries. Tehran; 2010. https://www.who.int/nmh/events/2010/Tehran_Background_Paper.pdf. Accessed 22 Aug 2020.
May SM, Li JTC. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015;36(1):4–10.
Article
Google Scholar
Squire SB, Thomson R, Namakhoma I, El Sony A, Kritski A, Madan J. Catastrophic care-seeking costs as an indicator for lung health. BMC Proc. BioMed Central Ltd.; 2015. p. S4. /pmc/articles/PMC4698768/?report=abstract. Accessed 22 Aug 2020.
Brouwer ED, Watkins D, Olson Z, Goett J, Nugent R, Levin C. Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review. BMC Public Health. 2015;15(1):1183. http://bmcpublichealth.biomedcentral.com/articles/https://doi.org/10.1186/s12889-015-2538-z. Accessed 19 Apr 2020.
Acharya L, Rau N, Udupa N, Rajan M, Vijayanarayana K. Assessment of cost of illness for diabetic patients in South Indian tertiary care hospital. J Pharm Bioallied Sci. 2016;8(4):314–20.
Article
Google Scholar
Adedapo KS, Fadiji IO, Orunmuyi AT, Ejeh JE, Osifo BO. High default rate in thyroid cancer management in Ibadan, Nigeria: a need for health insurance. Afr J Med Med Sci. 2012;1(41 Suppl):105–9.
Google Scholar
Ahuja S, Tsimicalis A, Lederman S, Bagai P, Martiniuk A, Srinivas S, et al. A pilot study to determine out-of-pocket expenditures by families of children being treated for cancer at public hospitals in New Delhi, India. Psychooncology. 2019;28(6):1349–53.
Article
Google Scholar
Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran, Iran. Diabetologia. 2009;52(8):1520–7.
Article
CAS
Google Scholar
Gillani AH, Aziz MM, Masood I, Saqib A, Yang C, Chang J, et al. Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab, Pakistan. Expert Rev Pharmacoecon Outcomes Res. 2018;18(6):647–53. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med13&AN=30052085http://pmt-eu.hosted.exlibrisgroup.com/openurl/46KIB_INST/46KIB_INST_services_page?sid=OVID:medline&id=pmid:30052085&id=doi:10.1080%2F14737167.2018.1503953&issn=1473-71.
Mateti U, Kunduru B, Akari S. Health-care cost of diabetes in South India: a cost of illness study. J Res Pharm Pract. 2013;2(3):114. /pmc/articles/PMC4076919/. Accessed 23 Feb 2021.
Zhang X, Liu S, Liu Y, Du J, Fu W, Zhao X, et al. Economic burden for lung cancer survivors in urban China. Int J Environ Res Public Health. 2017;14(3):308. http://www.mdpi.com/1660-4601/14/3/308. Accessed 19 Apr 2020.
Okoronkwo I, Ekpemiro J, Onwujekwe O, Nwaneri A, Iheanacho P. Socioeconomic inequities and payment coping mechanisms used in the treatment of type 2 diabetes mellitus in Nigeria. Niger J Clin Pract. 2016;19(1). https://www.ajol.info/index.php/njcp/article/view/129404. Accessed 19 Apr 2020.
Murphy A. iHEA Webinar—April 9, 2020: measuring financial protection for chronic illness in LMICs—YouTube. iHEA Staff; 2020. https://www.youtube.com/watch?v=UnLkhhElmZs. Accessed 25 May 2020.
Ó Céilleachair AJ, Hanly P, Skally M, O’Neill C, Fitzpatrick P, Kapur K, et al. Cost comparisons and methodological heterogeneity in cost-of-illness studies. Med Care. 2013;51(4):339–50. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005650-201304000-00009. Accessed 19 Apr 2020.
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Br Med J. 2013;346. www.icmje.org/coi_disclosure.pdf. Accessed 22 Aug 2020.
Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018;18:1–11.
Article
Google Scholar
Zorron Pu L, de Moura EG, Bernardo WM, Baracat FI, Mendonca EQ, Kondo A, et al. Analysis the significant risk factors on type 2 diabetes perspective of Bangladesh. PLoS One [Electronic Resour . 2018;13(1):1. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=30497441http://pmt-eu.hosted.exlibrisgroup.com/openurl/46KIB_INST/46KIB_INST_services_page?sid=OVID:medline&id=pmid:30497441&id=doi:10.1186%2Fs12884-018-2109-2&issn=1471-2393&is.
Pakseresht S, Garg S, Ingle G, Singh M. Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi. Indian J Cancer. 2011;48(4):428. http://www.indianjcancer.com/text.asp?2011/48/4/428/92263. Accessed 19 Apr 2020.
Marina A-M. The costs of breast cancer in a Mexican public health institution. Risk Manag Healthc Policy. 2008;1:15.
Article
Google Scholar
Hailu A, Mariam DH. Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study. BMC Cancer. 2013;13(1):1–8.
Article
Google Scholar
Ahuja S, Tsimicalis A, Lederman S, Bagai P, Martiniuk A, Srinivas S, et al. A pilot study to determine out-of-pocket expenditures by families of children being treated for cancer at public hospitals in New Delhi, India. Psycho Oncol. 2019;04:4. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medp&AN=30946504http://pmt-eu.hosted.exlibrisgroup.com/openurl/46KIB_INST/46KIB_INST_services_page?sid=OVID:medline&id=pmid:30946504&id=doi:10.1002%2Fpon.5077&issn=1057-9249&isbn=&volum.
World Health Organisation. WHO Cervical Cancer Prevention and Control Costing (C4P) Tool. WHO. World Health Organization; 2019. https://www.who.int/immunization/diseases/hpv/cervical_cancer_costing_tool/en/. Accessed 24 Mar 2020.
Bitran y Asociados, PATH. Final reports of technical review of costing tools. 2008. https://www.who.int/pmnch/topics/economics/costoolsreviewpack.pdf. Accessed 24 Mar 2020.
World Health Organisation. Tuberculosis patient cost surveys: a hand book. 2017. http://apps.who.int/bookorders. Accessed 25 May 2020.